Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.

NCT07367425
completednot_applicable

Metabolic Syndrome and Inflammatory Markers

NCT00433082
completednot_applicable

Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic Syndrome

NCT00429390

Clinical Trials (3)

Showing 3 of 3 trials
NCT07367425Not Applicable

Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.

Not Yet Recruiting
NCT00433082Not Applicable

Metabolic Syndrome and Inflammatory Markers

Completed
NCT00429390Not Applicable

Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic Syndrome

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3